Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Enanta Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ENTA
Nasdaq
2834
https://www.enanta.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
- May 8th, 2024 11:39 am
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2024 Earnings Call Transcript
- May 7th, 2024 2:24 pm
Q2 2024 Enanta Pharmaceuticals Inc Earnings Call
- May 7th, 2024 11:10 am
Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
- May 7th, 2024 11:00 am
Enanta Pharmaceuticals Inc (ENTA) (Q2 2024) Earnings Call Transcript Highlights: Navigating ...
- May 7th, 2024 7:07 am
Enanta Pharmaceuticals Reports Fiscal Q2 Results: A Closer Look Against Analyst Expectations
- May 6th, 2024 9:47 pm
Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Tops Revenue Estimates
- May 6th, 2024 9:10 pm
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
- May 6th, 2024 8:01 pm
Strong week for Enanta Pharmaceuticals (NASDAQ:ENTA) shareholders doesn't alleviate pain of five-year loss
- May 3rd, 2024 12:27 pm
Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Apr 30th, 2024 11:10 am
Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
- Apr 30th, 2024 11:00 am
Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
- Apr 29th, 2024 11:00 am
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
- Apr 17th, 2024 11:00 am
Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
- Mar 6th, 2024 12:00 pm
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
- Feb 12th, 2024 11:15 am
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2024 Earnings Call Transcript
- Feb 8th, 2024 2:07 pm
Q1 2024 Enanta Pharmaceuticals Inc Earnings Call
- Feb 8th, 2024 12:08 pm
Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Lags Revenue Estimates
- Feb 7th, 2024 10:10 pm
Enanta Pharmaceuticals Inc (ENTA) Reports Fiscal Q1 2024 Results: Royalty Revenue Declines Amid ...
- Feb 7th, 2024 9:59 pm
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
- Feb 7th, 2024 9:01 pm
Scroll